Health and Drug Alerts
Grapefruit juice: potential drug interactions
James Maskalyk
CMAJ August 06, 2002 167 (3) 279-280;
James Maskalyk
Editorial Fellow, CMAJ
In this issue
Article tools
Respond to this article
Grapefruit juice: potential drug interactions
James Maskalyk
CMAJ Aug 2002, 167 (3) 279-280;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Perspectives on drug withdrawals
- Natural products and adverse drug interactions
- Phase II Study of SU5416, a Small Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitor, in Patients with Refractory Multiple Myeloma
- Minerva
- SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes
- Risk of stroke, gangrene from ergot drug interactions
- Drug interactions with grapefruit
- Minerva